结合使用冷物理等离子体和化疗药物对抗冠状腺癌细胞
Andreas Nitsch1, Sara Qarqash1, Frank Schulze1
1Center for Orthopedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Str., 17475 Greifswald, Germany.
International journal of molecular sciences
|July 13, 2024
概括
这项研究探讨了结合冷物理等离子体 (CPP) 与治疗软骨肉瘤 (CS) 的化疗. 这种组合显著降低了瘤细胞的生长和增加了细胞死亡,为抗化学性CS提供了一个有希望的新方法.
科学领域:
- 在瘤学瘤学.
- 生物物理学的生物物理.
- 生物化学 生物化学
背景情况:
- 软骨肉瘤 (CS) 是一种罕见的骨癌,由于化学抵抗,治疗选择有限.
- 手术是主要的治疗方法,但攻击性亚型的预后不好.
- 冷物理等离子体 (CPP) 在体外显示对CS细胞的抗瘤作用.
研究的目的:
- 研究CPP与常见化疗剂在CS细胞上的协同效应.
- 评估这种联合治疗对CS细胞增殖,活力,新陈代谢和亡的影响.
主要方法:
- 两个CS细胞系 (CAL-78和SW1353) 用西斯普拉丁,多克索鲁比辛和温克里斯进行治疗.
- 确定了这些药物的IC20和IC50剂量.
- 然后用这些药物和CPP结合治疗细胞,以评估抗癌作用.
主要成果:
- CPP和细胞静止剂的组合显著降低了CS细胞的增殖和活力.
- 与单独的细胞静止治疗相比,在用联合治疗治疗的细胞中观察到亡信号的增加.
- 这种方法证明了对CS细胞的增强抗瘤活性.
结论:
- 将冷物理等离子体与化疗相结合,为克服冠状骨肉瘤化学阻抗提供了一个有前途的策略.
- 这种新的治疗方法可能会改善患有冠状动脉瘤的患者的临床结果.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509


